-
1
-
-
0037341535
-
Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use
-
Abdollahi M, Cushman M, Rosendaal FR. Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use. Thromb Haemost 2003;89:493-498.
-
(2003)
Thromb Haemost
, vol.89
, pp. 493-498
-
-
Abdollahi, M.1
Cushman, M.2
Rosendaal, F.R.3
-
2
-
-
37349104557
-
Cardiovascular risk factors and venous thromboembolism: a meta-analysis
-
Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW. Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation 2008; 117:93-102.
-
(2008)
Circulation
, vol.117
, pp. 93-102
-
-
Ageno, W.1
Becattini, C.2
Brighton, T.3
Selby, R.4
Kamphuisen, P.W.5
-
3
-
-
84555170228
-
Obesity and venous thrombosis: a review
-
Allman-Farinelli MA. Obesity and venous thrombosis: a review. Semin Thromb Hemost 2011;8:903-907.
-
(2011)
Semin Thromb Hemost
, vol.8
, pp. 903-907
-
-
Allman-Farinelli, M.A.1
-
4
-
-
0025891903
-
A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism
-
Anderson FA, Wheeler HB, Goldberg RJ, HosmerDW, Patwardhan NA, Jovanovic B, Forcier A, Dalen JE. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT study. Arch Intern Med 1991;151:933-938.
-
(1991)
The Worcester DVT study. Arch Intern Med
, vol.151
, pp. 933-938
-
-
Anderson, F.A.1
Wheeler, H.B.2
Goldberg, R.J.3
Hosmer, D.W.4
Patwardhan, N.A.5
Jovanovic, B.6
Forcier, A.7
Dalen, J.E.8
-
5
-
-
52649137538
-
Virchowand his triad: a question of attribution
-
Bagot CN, Arya R. Virchowand his triad: a question of attribution. Br J Haematol 2008; 143:180-190.
-
(2008)
Br J Haematol
, vol.143
, pp. 180-190
-
-
Bagot, C.N.1
Arya, R.2
-
6
-
-
84856809942
-
Antithrombotic therapy and prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-based Clinical Practice Guidelines
-
VTE, thrombophilia, antithrombotic therapy and pregnancy
-
Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvick PO. VTE, thrombophilia, antithrombotic therapy and pregnancy. Antithrombotic therapy and prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-based Clinical Practice Guidelines. Chest 2012;141:e691S-e736S.
-
(2012)
Chest
, vol.141
-
-
Bates, S.M.1
Greer, I.A.2
Middeldorp, S.3
Veenstra, D.L.4
Prabulos, A.M.5
Vandvick, P.O.6
-
7
-
-
36949015392
-
Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women
-
Bauersachs RM, Dudenhausen J, Faridi A, Fischer T, Fung S, Geisen U, Harenberg J, Herchenhan E, Keller F, Kemkes-Matthes B et al. Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women. Thromb Haemost 2007;98:1237-1245.
-
(2007)
Thromb Haemost
, vol.98
, pp. 1237-1245
-
-
Bauersachs, R.M.1
Dudenhausen, J.2
Faridi, A.3
Fischer, T.4
Fung, S.5
Geisen, U.6
Harenberg, J.7
Herchenhan, E.8
Keller, F.9
Kemkes-Matthes, B.10
-
8
-
-
84873396245
-
Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis
-
Bird ST, Hartzema AG, Brophy JM, Etminan M, Delaney JA. Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis. CMAJ 2013;185:E115-E120.
-
(2013)
CMAJ
, vol.185
-
-
Bird, S.T.1
Hartzema, A.G.2
Brophy, J.M.3
Etminan, M.4
Delaney, J.A.5
-
9
-
-
75749113228
-
Pulmonary embolism in pregnancy
-
Bourjeily G, Paidas M, Khalil H, Rosene-Montella K, Rodger M. Pulmonary embolism in pregnancy. Lancet 2010;375:500-512.
-
(2010)
Lancet
, vol.375
, pp. 500-512
-
-
Bourjeily, G.1
Paidas, M.2
Khalil, H.3
Rosene-Montella, K.4
Rodger, M.5
-
10
-
-
73949103286
-
The hemostatic system through aging and menopause
-
Bucciarelli P, Mannucci PM. The hemostatic system through aging and menopause. Climacteric 2009;12(Suppl. 1):47-51.
-
(2009)
Climacteric
, vol.12
, Issue.SUPPL. 1
, pp. 47-51
-
-
Bucciarelli, P.1
Mannucci, P.M.2
-
11
-
-
67650312805
-
The 'ART' of thrombosis: a review of arterial and venous thrombosis in assisted reproductive technology
-
Chan WS. The 'ART' of thrombosis: a review of arterial and venous thrombosis in assisted reproductive technology. Curr Opin Obstet Gynecol 2009;21:207-218.
-
(2009)
Curr Opin Obstet Gynecol
, vol.21
, pp. 207-218
-
-
Chan, W.S.1
-
12
-
-
41749083767
-
The 'ART' of thromboembolism: a review of assisted reproductive technology and thromboembolic complications
-
Chan WS, Dixon ME. The 'ART' of thromboembolism: a review of assisted reproductive technology and thromboembolic complications. Thromb Res 2008; 121:713-726.
-
(2008)
Thromb Res
, vol.121
, pp. 713-726
-
-
Chan, W.S.1
Dixon, M.E.2
-
13
-
-
51649098569
-
Guidelines for computed tomography and magnetic resonance imaging use during pregnancy and lactation
-
Chen MM, Coakley FV, Kamal A, Loros RK Jr. Guidelines for computed tomography and magnetic resonance imaging use during pregnancy and lactation. Obstet Gynecol 2008;112(2 Pt 1):333-340.
-
(2008)
Obstet Gynecol
, vol.112
, Issue.2 PART 1
, pp. 333-340
-
-
Chen, M.M.1
Coakley, F.V.2
Kamal, A.3
Loros, R.K.4
-
14
-
-
0345529975
-
Does this patient have pulmonary embolism
-
Chunilal SD, Eikelboom JW, Attia J, Miniati M, Panju AA, Simel DL, Ginsberg JS. Does this patient have pulmonary embolism? JAMA 2003;290:2849-2858.
-
(2003)
JAMA
, vol.290
, pp. 2849-2858
-
-
Chunilal, S.D.1
Eikelboom, J.W.2
Attia, J.3
Miniati, M.4
Panju, A.A.5
Simel, D.L.6
Ginsberg, J.S.7
-
16
-
-
0013351714
-
Cypoterone acetate (Dianette): risk of venous thromboembolism (VTE)
-
CSM.
-
CSM. Cypoterone acetate (Dianette): risk of venous thromboembolism (VTE). Curr Prob Pharmacovigil 2002;28:9-10.
-
(2002)
Curr Prob Pharmacovigil
, vol.28
, pp. 9-10
-
-
-
17
-
-
78649233245
-
O varian hyperstimulationsyndrome prevention strategies: cryopreservation of all embryos
-
D'AngeloA. Ovarian hyperstimulationsyndrome prevention strategies: cryopreservation of all embryos. Semin Reprod Med 2010;28:513-518.
-
(2010)
Semin Reprod Med
, vol.28
, pp. 513-518
-
-
D'Angelo, A.1
-
18
-
-
33749266340
-
The risk of recurrent venous thromboembolism in pregnancy and puerperium withoUT antithrombotic prophylaxis
-
DeStefanoV, Martinelli I, Rossi E, BattaglioliT, Za T, Mannucci PM, Leone G. The risk of recurrent venous thromboembolism in pregnancy and puerperium withoUT antithrombotic prophylaxis. Br J Haematol 2006;135:386-391.
-
(2006)
Br J Haematol
, vol.135
, pp. 386-391
-
-
DeStefano, V.1
Martinelli, I.2
Rossi, E.3
Battaglioli, T.4
Za, T.5
Mannucci, P.M.6
Leone, G.7
-
19
-
-
34047263992
-
The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance study on Oral Contraceptives based on 142,475 women-years of observation
-
Dinger JC, Heinemann LAJ, Kuhl-Habich D. The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance study on Oral Contraceptives based on 142,475 women-years of observation. Contraception 2007;75:344-354.
-
(2007)
Contraception
, vol.75
, pp. 344-354
-
-
Dinger, J.C.1
Heinemann, L.A.J.2
Kuhl-Habich, D.3
-
20
-
-
0036181630
-
Metabolic effects of implantable steroid contraceptives for women
-
Dorflinger LJ. Metabolic effects of implantable steroid contraceptives for women. Contraception 2002;65:47-62.
-
(2002)
Contraception
, vol.65
, pp. 47-62
-
-
Dorflinger, L.J.1
-
21
-
-
0032144827
-
Effects on the haemostatic system and liver function in relation to Implanon and Norplant
-
Egberg N, van Beek A, Gunnervik C, Hulkko S, Hirvonen E, Larsson-Cohn U, Bennink HC. Effects on the haemostatic system and liver function in relation to Implanon and Norplant. A prospective randomized clinical trial. Contraception 1998;58:93-98.
-
(1998)
A prospective randomized clinical trial. Contraception
, vol.58
, pp. 93-98
-
-
Egberg, N.1
van Beek, A.2
Gunnervik, C.3
Hulkko, S.4
Hirvonen, E.5
Larsson-Cohn, U.6
Bennink, H.C.7
-
22
-
-
0032851668
-
Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden
-
Eichinger S, Weltermann A, Philipp K, Hafner E, Kaider A, Kittl EM, Brenner B, Mannhalter C, Lechner K, Kyrle PA. Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden. Thromb Haemost 1999;82:1232-1236.
-
(1999)
Thromb Haemost
, vol.82
, pp. 1232-1236
-
-
Eichinger, S.1
Weltermann, A.2
Philipp, K.3
Hafner, E.4
Kaider, A.5
Kittl, E.M.6
Brenner, B.7
Mannhalter, C.8
Lechner, K.9
Kyrle, P.A.10
-
23
-
-
84862000489
-
Hematocrit and the risk of recurrent venous thrombosis: a prospective cohort study
-
Eischer L, Tscholl V, Heinze G, Traby L, Kyrle PA, Eichinger S. Hematocrit and the risk of recurrent venous thrombosis: a prospective cohort study. PLoS One 2012;7:e38705.
-
(2012)
PLoS One
, vol.7
-
-
Eischer, L.1
Tscholl, V.2
Heinze, G.3
Traby, L.4
Kyrle, P.A.5
Eichinger, S.6
-
24
-
-
84882610740
-
-
European Medicines Agency. EMA update on Diane 35 (cyproterone acetate 2mg, ethinylestradiol 35mcg) and generics for treatment of acne following French decision to suspend marketing authorization, January 2013
-
European Medicines Agency. EMA update on Diane 35 (cyproterone acetate 2mg, ethinylestradiol 35mcg) and generics for treatment of acne following French decision to suspend marketing authorization, January 2013. http://www.ema. europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/01/news_ detail_001703.jsp&mid=WC0b01ac058004d5c1.
-
-
-
-
25
-
-
84882613633
-
FDA, U.S
-
FDA, U.S. Food and Drug Administration, 2011. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm273 039.htm.
-
(2011)
Food and Drug Administration
-
-
-
26
-
-
0035822254
-
Adjusting Europe's drug regulation to public health needs
-
Garattini S, Bertele V. Adjusting Europe's drug regulation to public health needs. Lancet 2002;358:64-67.
-
(2001)
Lancet
, vol.358
, pp. 64-67
-
-
Garattini, S.1
Bertele, V.2
-
27
-
-
84860835430
-
Pulmonary embolism and deep vein thrombosis
-
Goldhaber SZ, Bounameaux H. Pulmonary embolism and deep vein thrombosis. Lancet 2012;379:1835-1846.
-
(2012)
Lancet
, vol.379
, pp. 1835-1846
-
-
Goldhaber, S.Z.1
Bounameaux, H.2
-
28
-
-
34249751711
-
Effect of depomedroxyprogesterone acetate on coagulation parameter: a pilot study
-
Goldstein J, Cushman M, Badger GJ, Johnson JV. Effect of depomedroxyprogesterone acetate on coagulation parameter: a pilot study. Fertil Steril 2007;87:1267-1270.
-
(2007)
Fertil Steril
, vol.87
, pp. 1267-1270
-
-
Goldstein, J.1
Cushman, M.2
Badger, G.J.3
Johnson, J.V.4
-
29
-
-
27644460334
-
Systematic review and meta-analysis of the diagnostic accuracy of ultrasonography for deep vein thrombosis
-
Goodacre S, Sampson F, Thomas S, van Beek E, Sutton A. Systematic review and meta-analysis of the diagnostic accuracy of ultrasonography for deep vein thrombosis. BMC Med Imaging 2005;5:6.
-
(2005)
BMC Med Imaging
, vol.5
, pp. 6
-
-
Goodacre, S.1
Sampson, F.2
Thomas, S.3
van Beek, E.4
Sutton, A.5
-
30
-
-
84856373752
-
The progestogen content of combined oral contraceptives and venous thromboembolic risk
-
Hannaford PC. The progestogen content of combined oral contraceptives and venous thromboembolic risk. BMJ 2011;343:d6592.
-
(2011)
BMJ
, vol.343
-
-
Hannaford, P.C.1
-
31
-
-
84860168391
-
No evidence that assisted reproduction increases the risk of thrombosis: a Danish national cohort study
-
Hansen AT, Kesmodel US, Juul S, Hvas AM. No evidence that assisted reproduction increases the risk of thrombosis: a Danish national cohort study. Hum Reprod 2012;27:1499-1503.
-
(2012)
Hum Reprod
, vol.27
, pp. 1499-1503
-
-
Hansen, A.T.1
Kesmodel, U.S.2
Juul, S.3
Hvas, A.M.4
-
32
-
-
0033028689
-
Oral progestogen-only contraceptives and cardiovascular risk: results from the Transnational Study on Oral Contraceptives and the Health of Young Women
-
Heinemann LA, Assmann A, DoMinh T, Garbe E. Oral progestogen-only contraceptives and cardiovascular risk: results from the Transnational Study on Oral Contraceptives and the Health of Young Women. Eur J Contracept Reprod Health Care 1999;4:67-73.
-
(1999)
Eur J Contracept Reprod Health Care
, vol.4
, pp. 67-73
-
-
Heinemann, L.A.1
Assmann, A.2
DoMinh, T.3
Garbe, E.4
-
33
-
-
32544431531
-
The epidemiology of venous thromboembolism in the community: implications for prevention and management
-
Heit JA. The epidemiology of venous thromboembolism in the community: implications for prevention and management. J Thromb Thrombolysis 2006;21: 23-29.
-
(2006)
J Thromb Thrombolysis
, vol.21
, pp. 23-29
-
-
Heit, J.A.1
-
34
-
-
28044439149
-
Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study
-
Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, Melton LJ III. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med 2005;143:697-706.
-
(2005)
Ann Intern Med
, vol.143
, pp. 697-706
-
-
Heit, J.A.1
Kobbervig, C.E.2
James, A.H.3
Petterson, T.M.4
Bailey, K.R.5
Melton, L.J.6
-
35
-
-
0037393051
-
Hemostasis during normal pregnancy and puerperium
-
Hellgren M. Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost 2003;29:125-130.
-
(2003)
Semin Thromb Hemost
, vol.29
, pp. 125-130
-
-
Hellgren, M.1
-
36
-
-
84873036155
-
Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilisation: cross sectional study
-
Henriksson P, Westerlund E, Wallen H, Brandt L, Hovatta O, Ekbom A. Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilisation: cross sectional study. BMJ 2013;346:e8632.
-
(2013)
BMJ
, vol.346
-
-
Henriksson, P.1
Westerlund, E.2
Wallen, H.3
Brandt, L.4
Hovatta, O.5
Ekbom, A.6
-
37
-
-
0034533428
-
Increased risk of recurrent venous thromboembolism during hormone replacement therapy-results of the randomized, double-blind, placebocontrolled estrogen in venous thromboembolism trial (EVTET)
-
Hoibraaten E, Qvigstad E, Arnesen H, Larsen S, Wickstrom E, Sandset PM. Increased risk of recurrent venous thromboembolism during hormone replacement therapy-results of the randomized, double-blind, placebocontrolled estrogen in venous thromboembolism trial (EVTET). Thromb Haemost 2000;84:961-967.
-
(2000)
Thromb Haemost
, vol.84
, pp. 961-967
-
-
Hoibraaten, E.1
Qvigstad, E.2
Arnesen, H.3
Larsen, S.4
Wickstrom, E.5
Sandset, P.M.6
-
38
-
-
0014962032
-
ICSI (Institute for Clinical Systems Improvement).
-
(10 May 2012, date last accessed). Inman WH, VesseyMP, Westerholm B, Engelund A. Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs. BMJ
-
ICSI (Institute for Clinical Systems Improvement). http://www.icsi.org/knowledge/detail.asp?catID=29&itemID=202 (10 May 2012, date last accessed). Inman WH, VesseyMP, Westerholm B, Engelund A. Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs. BMJ 1970;2:203-209.
-
(1970)
, vol.2
, pp. 203-209
-
-
-
39
-
-
43749117523
-
Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study
-
Jacobsen AF, Skjeldestad FE, Sandset PM. Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study. J Thromb Haemost 2008; 6:905-912.
-
(2008)
J Thromb Haemost
, vol.6
, pp. 905-912
-
-
Jacobsen, A.F.1
Skjeldestad, F.E.2
Sandset, P.M.3
-
40
-
-
46349106976
-
An overview of venous thromboembolism: impact, risks, and issues in prophylaxis
-
Jaffer AK. An overview of venous thromboembolism: impact, risks, and issues in prophylaxis. Cleve Clin J Med 2008;75(Suppl. 3):S3-S6.
-
(2008)
Cleve Clin J Med
, vol.75
, Issue.SUPPL. 3
-
-
Jaffer, A.K.1
-
41
-
-
33646117733
-
Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality
-
James AH, Jamison MG, Brancazio LR, Myers ER. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol 2006;194:1311-1315.
-
(2006)
Am J Obstet Gynecol
, vol.194
, pp. 1311-1315
-
-
James, A.H.1
Jamison, M.G.2
Brancazio, L.R.3
Myers, E.R.4
-
42
-
-
84866135244
-
Elevation in D-dimer concentrations is positively correlated with gestation in normal uncomplicated pregnancy
-
JeremiahZA, Adias TC, Opiah M, George SP, MgbereO, Essien EJ. Elevation in D-dimer concentrations is positively correlated with gestation in normal uncomplicated pregnancy. Int J Womens Health 2012;4:437-443.
-
(2012)
Int J Womens Health
, vol.4
, pp. 437-443
-
-
Jeremiah, Z.A.1
Adias, T.C.2
Opiah, M.3
George, S.P.4
Mgbere, O.5
Essien, E.J.6
-
43
-
-
0034638671
-
Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case- control analysis
-
Jick H, Kaye JA, Vasilakis-Scaramozza C, Jick SS. Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case- control analysis. BMJ 2000;321:1190-1195.
-
(2000)
BMJ
, vol.321
, pp. 1190-1195
-
-
Jick, H.1
Kaye, J.A.2
Vasilakis-Scaramozza, C.3
Jick, S.S.4
-
44
-
-
2942569918
-
The risk of recurrent venous thromboembolism in men and women
-
Kyrle PA, Minar E, Bialonczyk C, Hirschl M, Weltermann A, Eichinger S. The risk of recurrent venous thromboembolism in men and women. N Engl J Med 2004; 350:2558-2563.
-
(2004)
N Engl J Med
, vol.350
, pp. 2558-2563
-
-
Kyrle, P.A.1
Minar, E.2
Bialonczyk, C.3
Hirschl, M.4
Weltermann, A.5
Eichinger, S.6
-
45
-
-
0036623663
-
Venous thromboembolism in young women; role of thrombophilic mutations and oral contraceptive use
-
Legnani C, Palareti G, Guazzaloca G, Cosmi B, Lunghi B, Bernardi F, Coccheri S. Venous thromboembolism in young women; role of thrombophilic mutations and oral contraceptive use. Eur Heart J 2002;23:984-990.
-
(2002)
Eur Heart J
, vol.23
, pp. 984-990
-
-
Legnani, C.1
Palareti, G.2
Guazzaloca, G.3
Cosmi, B.4
Lunghi, B.5
Bernardi, F.6
Coccheri, S.7
-
46
-
-
84882640078
-
aringins on two birth control pills are too weak, FDA panel rules
-
Lenzer J. Waringins on two birth control pills are too weak, FDA panel rules. BMJ 2011; 343:1227.
-
(2011)
BMJ
, vol.343
, pp. 1227
-
-
Lenzer, J.W.1
-
47
-
-
69949088549
-
Hormonal contraception and risk of venous thromboembolism: national follow-up study
-
Lidegaard O, Loøkkegaard E, Svendsen AL, Agger C. Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ 2009;339:b2890.
-
(2009)
BMJ
, vol.339
-
-
Lidegaard, O.1
Loøkkegaard, E.2
Svendsen, A.L.3
Agger, C.4
-
48
-
-
83655195179
-
Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9
-
Lidegaard O, Nielsen LH, Skovlund CV, Skjeldestad FE, Loøkkegaard E. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9. BMJ 2011; 343:d6423.
-
(2011)
BMJ
, vol.343
-
-
Lidegaard, O.1
Nielsen, L.H.2
Skovlund, C.V.3
Skjeldestad, F.E.4
Loøkkegaard, E.5
-
50
-
-
84862897224
-
Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10
-
Lidegaard O, Nielsen LH, SkovlundCW, Loøkkegaard E. Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10. BMJ 2012b; 344:e2990.
-
(2012)
BMJ
, vol.344
-
-
Lidegaard, O.1
Nielsen, L.H.2
Skovlund, C.W.3
Loøkkegaard, E.4
-
51
-
-
80051576987
-
Is obstetric thromboprophylaxis with low-molecular-weight heparin effective? Yes, if administered properly
-
Lindqvist PG, Hellgren M. Is obstetric thromboprophylaxis with low-molecular-weight heparin effective? Yes, if administered properly. J Thromb Haemost 2011; 9:1669-1670.
-
(2011)
J Thromb Haemost
, vol.9
, pp. 1669-1670
-
-
Lindqvist, P.G.1
Hellgren, M.2
-
52
-
-
0030860570
-
Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use
-
Lowe GD, Rumley A, Woodward M, Morrison CE, Philippou H, Lane DA, Tunstall-Pedoe H. Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use. Br J Haematol 1997;97:775-784.
-
(1997)
Br J Haematol
, vol.97
, pp. 775-784
-
-
Lowe, G.D.1
Rumley, A.2
Woodward, M.3
Morrison, C.E.4
Philippou, H.5
Lane, D.A.6
Tunstall-Pedoe, H.7
-
53
-
-
84865724931
-
Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis
-
Mantha S, Karp R, Raghavan V, Terrin N, Bauer KA, Zwicker JI. Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis. BMJ 2012;345:e4944.
-
(2012)
BMJ
, vol.345
-
-
Mantha, S.1
Karp, R.2
Raghavan, V.3
Terrin, N.4
Bauer, K.A.5
Zwicker, J.I.6
-
54
-
-
0036253139
-
Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium
-
Martinelli I, De Stefano V, Taioli E, Paciaroni K, Rossi E, Mannucci PM. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium. Thromb Haemost 2002;87:791-795.
-
(2002)
Thromb Haemost
, vol.87
, pp. 791-795
-
-
Martinelli, I.1
De Stefano, V.2
Taioli, E.3
Paciaroni, K.4
Rossi, E.5
Mannucci, P.M.6
-
55
-
-
0028574279
-
Progestin-only oral contraception: a comprehensive review
-
McCann MF, Potter LS. Progestin-only oral contraception: a comprehensive review. Contraception 1994;50(Suppl. 1):S1-195.
-
(1994)
Contraception
, vol.50
, Issue.SUPPL. 1
-
-
McCann, M.F.1
Potter, L.S.2
-
56
-
-
84882582196
-
Medicines and Healthcare Products Regulatory Agency.
-
Updated advice. Drug Safety Update
-
Medicines and Healthcare Products Regulatory Agency. Hormone replacement therapy. Updated advice. Drug Safety Update 2007;1:2-6.
-
(2007)
Hormone replacement therapy
, vol.1
, pp. 2-6
-
-
-
57
-
-
0032945755
-
Die Inzidenz von Lungenembolien bei venosen Thrombosen
-
Mostbeck A. Die Inzidenz von Lungenembolien bei venosen Thrombosen. Wien Med Wochenschr 1999;149:72-75.
-
(1999)
Wien Med Wochenschr
, vol.149
, pp. 72-75
-
-
Mostbeck, A.1
-
58
-
-
0013846522
-
Thromboembolic phenomena after ovarian stimulation with human gonadotrophins
-
Mozes M, Bogokowsky H, Antebi E, Lunenfeld B, Rabau E, SerrDM, David A, Salomy M. Thromboembolic phenomena after ovarian stimulation with human gonadotrophins. Lancet 1965;2:1213-1215.
-
(1965)
Lancet
, vol.2
, pp. 1213-1215
-
-
Mozes, M.1
Bogokowsky, H.2
Antebi, E.3
Lunenfeld, B.4
Rabau, E.5
Serr, D.M.6
David, A.7
Salomy, M.8
-
59
-
-
34147169563
-
Incidence and mortality of venous thrombosis: a population-based study
-
Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstroøm J. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 2007;5:692-699.
-
(2007)
J Thromb Haemost
, vol.5
, pp. 692-699
-
-
Naess, I.A.1
Christiansen, S.C.2
Romundstad, P.3
Cannegieter, S.C.4
Rosendaal, F.R.5
Hammerstroøm, J.6
-
60
-
-
59449086093
-
Prophylaxis of VTE in women-during assisted reproductive techniques
-
Nelson SM. Prophylaxis of VTE in women-during assisted reproductive techniques. Thromb Res 2009;123(Suppl. 3):S8-S15.
-
(2009)
Thromb Res
, vol.123
, Issue.SUPPL. 3
-
-
Nelson, S.M.1
-
61
-
-
84882729174
-
Venousthromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing; NICE Clinical Guideline
-
NICE (National Institute on Clinical Excellence) (26 February 2013, date last accessed).
-
NICE (National Institute on Clinical Excellence). Venousthromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing; NICE Clinical Guideline No. 144. http://www.nice.org.uk/nicemedia/live/13767/59711/59711.pdf (26 February 2013, date last accessed).
-
, vol.144
-
-
-
62
-
-
0026764834
-
A prospective study of the incidence of deep-vein thrombosis within a defined urban population
-
Nordstrom M, Lindblad B, Bergqvist D, Kjellstrom T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 1992;232:155-160.
-
(1992)
J Intern Med
, vol.232
, pp. 155-160
-
-
Nordstrom, M.1
Lindblad, B.2
Bergqvist, D.3
Kjellstrom, T.4
-
63
-
-
84868095303
-
Is polycystic ovary syndrome another risk factor for venous thromboembolism? United States, 2003-2008
-
e8
-
Okoroh EM, Hooper WC, Atrash HK, Yusuf HR, Boulet SL. Is polycystic ovary syndrome another risk factor for venous thromboembolism? United States, 2003-2008. Am J Obstet Gynecol 2012;207:377.e1-377.e8.
-
(2012)
Am J Obstet Gynecol
, vol.207
, Issue.377
-
-
Okoroh, E.M.1
Hooper, W.C.2
Atrash, H.K.3
Yusuf, H.R.4
Boulet, S.L.5
-
64
-
-
77955924407
-
Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women
-
Olie V.,Canonico M.,Scarabin P.Y.;Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women:Curr Opin Hematol:2010:17;457-463.
-
(2010)
Curr Opin Hematol
, vol.17
, pp. 457-463
-
-
Olie, V.1
Canonico, M.2
Scarabin, P.Y.3
-
65
-
-
79959952636
-
Hormone therapy and recurrence of venous thromboembolism among postmenopausal women
-
Olie V, Plu-Bureau G, Conard J, Horellou MH, Canonico M, Scarabin PY. Hormone therapy and recurrence of venous thromboembolism among postmenopausal women. Menopause 2011;18:488-493.
-
(2011)
Menopause
, vol.18
, pp. 488-493
-
-
Olie, V.1
Plu-Bureau, G.2
Conard, J.3
Horellou, M.H.4
Canonico, M.5
Scarabin, P.Y.6
-
66
-
-
0028324624
-
Thrombotic risk of women with hereditary antithrombin III-, protein C- and protein S-deficiency taking oral contraceptive medication. The GTH Study Group on Natural Inhibitors
-
Pabinger I, Schneider B. Thrombotic risk of women with hereditary antithrombin III-, protein C- and protein S-deficiency taking oral contraceptive medication. The GTH Study Group on Natural Inhibitors. Thromb Haemost 1994;71: 548-552.
-
(1994)
Thromb Haemost
, vol.71
, pp. 548-552
-
-
Pabinger, I.1
Schneider, B.2
-
67
-
-
40949151066
-
Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study
-
Pomp ER, Lenselink AM, Rosendaal FR, Doggen CJ. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost 2008;6:632-637.
-
(2008)
J Thromb Haemost
, vol.6
, pp. 632-637
-
-
Pomp, E.R.1
Lenselink, A.M.2
Rosendaal, F.R.3
Doggen, C.J.4
-
69
-
-
84882639824
-
RCOG(RoyalCollege ofObstetricians andGynaecologists).
-
Green-top Guideline
-
RCOG(RoyalCollege ofObstetricians andGynaecologists). Venous thromboembolism and hormonal contraception. Green-top Guideline No. 40, 2010.
-
(2010)
Venous thromboembolism and hormonal contraception
, vol.40
-
-
-
70
-
-
84882588728
-
RCOG (Royal College of Obstetricians and Gynaecologists).
-
Green-top Guideline, 3rd edition
-
RCOG (Royal College of Obstetricians and Gynaecologists). Venous thromboembolism and hormone replacement therapy. Green-top Guideline No. 19, 3rd edition, 2011.
-
(2011)
Venous thromboembolism and hormone replacement therapy
, vol.19
-
-
-
71
-
-
77953573349
-
Hormone replacement therapy and the risk of venous thromboembolism: a population-based study
-
Renoux C, Dell'Aniello S, Suissa S. Hormone replacement therapy and the risk of venous thromboembolism: a population-based study. J Thromb Haemost 2010; 8:979-986.
-
(2010)
J Thromb Haemost
, vol.8
, pp. 979-986
-
-
Renoux, C.1
Dell'Aniello, S.2
Suissa, S.3
-
72
-
-
79952078261
-
Prophylaxis with low-dose low-molecular weight heparin during pregnancy and postpartum
-
is it effective? J Thromb Haemsot
-
Roeters van Lennep JE, Meijer E, Klumper FJCM, Middeldorp JM, BloemenkampKWM, Middeldorp S. Prophylaxis with low-dose low-molecular weight heparin during pregnancy and postpartum: is it effective? J Thromb Haemsot 2011;9: 473-480.
-
(2011)
, vol.9
, pp. 473-480
-
-
Roeters van Lennep, J.E.1
Meijer, E.2
Klumper, F.J.C.M.3
Middeldorp, J.M.4
Bloemenkamp, K.W.M.5
Middeldorp, S.6
-
73
-
-
0033519051
-
Venous thrombosis: a multicausal disease
-
Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999; 353:1167-1173.
-
(1999)
Lancet
, vol.353
, pp. 1167-1173
-
-
Rosendaal, F.R.1
-
74
-
-
0141832939
-
Estrogens, progestogens and thrombosis
-
Rosendaal FR, van Hylckama Vlieg A, Tanis BC, Helmerhorst FM. Estrogens, progestogens and thrombosis. J Thromb Haemost 2003;1:1371-1380.
-
(2003)
J Thromb Haemost
, vol.1
, pp. 1371-1380
-
-
Rosendaal, F.R.1
van Hylckama Vlieg, A.2
Tanis, B.C.3
Helmerhorst, F.M.4
-
75
-
-
0035190596
-
A 16-year haemodynamic follow-up of women with pregnancy-related medically treated iliofemoral deep venous thrombosis
-
Rosfors S, Noren A, Hjertberg R, Persson L, Lillthors K, Torngren S. A 16-year haemodynamic follow-up of women with pregnancy-related medically treated iliofemoral deep venous thrombosis. Eur J Vasc Endovasc Surg 2001;22:448-455.
-
(2001)
Eur J Vasc Endovasc Surg
, vol.22
, pp. 448-455
-
-
Rosfors, S.1
Noren, A.2
Hjertberg, R.3
Persson, L.4
Lillthors, K.5
Torngren, S.6
-
76
-
-
84155172808
-
Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles
-
Rova K, Passmark H, Lindqvist PG. Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles. Fertil Steril 2012;97:95-100.
-
(2012)
Fertil Steril
, vol.97
, pp. 95-100
-
-
Rova, K.1
Passmark, H.2
Lindqvist, P.G.3
-
77
-
-
67650341330
-
Combined jugular and subclavian vein thrombosis following assisted reproductive technology- new observation
-
Salomon O, Schiby G, Heiman Z, Avivi K, Sigal C, Levran D, Dor J, Itzchak Y. Combined jugular and subclavian vein thrombosis following assisted reproductive technology- new observation. Fertil Steril 2009;92:620-625.
-
(2009)
Fertil Steril
, vol.92
, pp. 620-625
-
-
Salomon, O.1
Schiby, G.2
Heiman, Z.3
Avivi, K.4
Sigal, C.5
Levran, D.6
Dor, J.7
Itzchak, Y.8
-
78
-
-
77955875684
-
Hot flushes: are there effective alternatives to estrogen
-
Menopause Int
-
Sassarini J, Lumsden MA. Hot flushes: are there effective alternatives to estrogen? Menopause Int 2010;16:81-88.
-
(2010)
, vol.16
, pp. 81-88
-
-
Sassarini, J.1
Lumsden, M.A.2
-
79
-
-
0042737410
-
Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk
-
Scarabin PY, Oger E, Plu-Bureau G. Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk. Lancet 2003; 362:428-432.
-
(2003)
Lancet
, vol.362
, pp. 428-432
-
-
Scarabin, P.Y.1
Oger, E.2
Plu-Bureau, G.3
-
80
-
-
72449212348
-
Anthropometry, body fat, and venous thromboembolism: a Danish follow-up study
-
Severinsen MT, Kristensen SR, Johnsen SP, Dethlefsen C, Tjoønneland A, Overvad K. Anthropometry, body fat, and venous thromboembolism: a Danish follow-up study. Circulation 2009;120:1850-1857.
-
(2009)
Circulation
, vol.120
, pp. 1850-1857
-
-
Severinsen, M.T.1
Kristensen, S.R.2
Johnsen, S.P.3
Dethlefsen, C.4
Tjoønneland, A.5
Overvad, K.6
-
81
-
-
0032559775
-
Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study
-
Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'FallonWM, Melton LJ 3rd. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998;158:585-593.
-
(1998)
Arch Intern Med
, vol.158
, pp. 585-593
-
-
Silverstein, M.D.1
Heit, J.A.2
Mohr, D.N.3
Petterson, T.M.4
O'Fallon, W.M.5
Melton, L.J.6
-
82
-
-
0000662461
-
Incidence of venous thromboembolism in families with inherited thrombophili
-
Simioni P, Sanson BJ, Prandoni P, Tormene D, Friederich PW, Girolami B, Gavasso S, Huisman MV, Buller HR, Wouter ten Cate J et al. Incidence of venous thromboembolism in families with inherited thrombophilia. Thromb Haemost 1999;81:198-202.
-
(1999)
Thromb Haemost
, vol.81
, pp. 198-202
-
-
Simioni, P.1
Sanson, B.J.2
Prandoni, P.3
Tormene, D.4
Friederich, P.W.5
Girolami, B.6
Gavasso, S.7
Huisman, M.V.8
Buller, H.R.9
Wouter ten Cate, J.10
-
83
-
-
24744470476
-
Obesity as a risk factor in venous thromboembolism
-
Stein PD, Beemath A, Olson RE. Obesity as a risk factor in venous thromboembolism. Am J Med 2005;118:978-980.
-
(2005)
Am J Med
, vol.118
, pp. 978-980
-
-
Stein, P.D.1
Beemath, A.2
Olson, R.E.3
-
84
-
-
0030764967
-
First-time use of newer oral contraceptives and the risk of venous thromboembolism
-
Suissa S, Blais L, Spitzer WO, Cusson J, Lewis M, Heinemann L. First-time use of newer oral contraceptives and the risk of venous thromboembolism. Contraception 1997; 56:141-146.
-
(1997)
Contraception
, vol.56
, pp. 141-146
-
-
Suissa, S.1
Blais, L.2
Spitzer, W.O.3
Cusson, J.4
Lewis, M.5
Heinemann, L.6
-
85
-
-
84868132798
-
The MillionWomen Study Collaborators. Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study
-
First published online October 30, 2012. doi:10.1111/j.1538-7836.2012.04919.x
-
Sweetland S, Beral V, Balkwill A, Liu B, Benson VS, Canonico M, Green J, Reeves GK., The MillionWomen Study Collaborators. Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study. J Thromb Haemost 2012;10:2277-2286. First published online October 30, 2012. doi:10.1111/j.1538-7836.2012.04919.x
-
(2012)
J Thromb Haemost
, vol.10
, pp. 2277-2286
-
-
Sweetland, S.1
Beral, V.2
Balkwill, A.3
Liu, B.4
Benson, V.S.5
Canonico, M.6
Green, J.7
Reeves, G.K.8
-
86
-
-
1142267008
-
The Writing Group for theWomen's Health Initiative. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative
-
The Writing Group for theWomen's Health Initiative. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative. JAMA 2002;255:3243-3253.
-
(2002)
JAMA
, vol.255
, pp. 3243-3253
-
-
-
87
-
-
0028029477
-
Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation
-
Vandenbroucke JP, KosterT, Briet E, Reitsma PH, Bertina RM, Rosendaal FR. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994;344:1453-1457.
-
(1994)
Lancet
, vol.344
, pp. 1453-1457
-
-
Vandenbroucke, J.P.1
Koster, T.2
Briet, E.3
Reitsma, P.H.4
Bertina, R.M.5
Rosendaal, F.R.6
-
88
-
-
79251587186
-
Hormone therapies and venous thromboembolism: where are we now
-
J Thromb Haemost
-
van Hylckama Vlieg A, Middeldorp S. Hormone therapies and venous thromboembolism: where are we now? J Thromb Haemost 2011;9:257-266.
-
(2011)
, vol.9
, pp. 257-266
-
-
van Hylckama Vlieg, A.1
Middeldorp, S.2
-
89
-
-
69949103268
-
The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study
-
van Hylckama Vlieg A, Helmerhorst FM, Vandenbroucke JP, Doggen CJ, Rosendaal FR. The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. BMJ 2009; 339:b2921.
-
(2009)
BMJ
, vol.339
-
-
van Hylckama Vlieg, A.1
Helmerhorst, F.M.2
Vandenbroucke, J.P.3
Doggen, C.J.4
Rosendaal, F.R.5
-
90
-
-
78149282226
-
The risk of deep venous thrombosis associated with injectable depot-medroxyprogesterone acetate contraceptives or a levonorgestrel intrauterine device
-
van Hylckama Vlieg A, Helmerhorst FM, Rosendaal FR. The risk of deep venous thrombosis associated with injectable depot-medroxyprogesterone acetate contraceptives or a levonorgestrel intrauterine device. Arterioscler Thromb Vasc Biol 2010;30:2297-2300.
-
(2010)
Arterioscler Thromb Vasc Biol
, vol.30
, pp. 2297-2300
-
-
van Hylckama Vlieg, A.1
Helmerhorst, F.M.2
Rosendaal, F.R.3
-
91
-
-
64849114049
-
The effect of the levonorgestrel-releasing intrauterine system on the resistance to activated protein C (APC)
-
van Vliet HA, Tchaikovski SN, Rosendaal FR, Rosing J, Helmerhorst FM. The effect of the levonorgestrel-releasing intrauterine system on the resistance to activated protein C (APC). Thromb Haemost 2009;101:691-695.
-
(2009)
Thromb Haemost
, vol.101
, pp. 691-695
-
-
van Vliet, H.A.1
Tchaikovski, S.N.2
Rosendaal, F.R.3
Rosing, J.4
Helmerhorst, F.M.5
-
92
-
-
80052140272
-
Thrombotic risk during oral contraceptive use and pregnancy inwomenwith factorV Leiden or prothrombin mutation: a rational approach to contraception
-
van Vlijmen EF, Veeger NJ, Middeldorp S, Hamulyak K, Prins MH, Buller HR, Meijer K. Thrombotic risk during oral contraceptive use and pregnancy inwomenwith factorV Leiden or prothrombin mutation: a rational approach to contraception. Blood 2011; 118:2055-2061.
-
(2011)
Blood
, vol.118
, pp. 2055-2061
-
-
van Vlijmen, E.F.1
Veeger, N.J.2
Middeldorp, S.3
Hamulyak, K.4
Prins, M.H.5
Buller, H.R.6
Meijer, K.7
-
93
-
-
34547801249
-
Use of the etonorestrel-releasing implant is associated with hypoactivation of the coagulation cascade
-
Vieria CS, Ferriana RA, Garcia AA, Pinatoa MC, Azevedo GD, Gomez MK, Silva de-Sa MF. Use of the etonorestrel-releasing implant is associated with hypoactivation of the coagulation cascade. Hum Reprod 2007;22:196-201.
-
(2007)
Hum Reprod
, vol.22
, pp. 196-201
-
-
Vieria, C.S.1
Ferriana, R.A.2
Garcia, A.A.3
Pinatoa, M.C.4
Azevedo, G.D.5
Gomez, M.K.6
Silva de-Sa, M.F.7
-
94
-
-
19944433631
-
Familial thrombophilia and lifetime risk of venous thrombosis
-
VossenCY, Conard J, Fontcuberta J, Makris M, Van Der Meer FJ, Pabinger I, Palareti G, Preston FE, Scharrer I, Souto JC et al. Familial thrombophilia and lifetime risk of venous thrombosis. J Thromb Haemost 2004;2:1526-1532.
-
(2004)
J Thromb Haemost
, vol.2
, pp. 1526-1532
-
-
Vossen, C.Y.1
Conard, J.2
Fontcuberta, J.3
Makris, M.4
Van Der Meer, F.J.5
Pabinger, I.6
Palareti, G.7
Preston, F.E.8
Scharrer, I.9
Souto, J.C.10
-
95
-
-
0031588519
-
Value of assessment of pretest probability of deep-vein thrombosis in clinical management
-
Wells PS, Anderson DR, Bormanis J, Guy F, Mitchell M, Gray L, Clement C, Robinson KS, Lewandowski B. Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet 1997;350:1795-1798.
-
(1997)
Lancet
, vol.350
, pp. 1795-1798
-
-
Wells, P.S.1
Anderson, D.R.2
Bormanis, J.3
Guy, F.4
Mitchell, M.5
Gray, L.6
Clement, C.7
Robinson, K.S.8
Lewandowski, B.9
-
96
-
-
17444361887
-
Use of a clinical model for safe management of patients with suspected pulmonary embolism
-
Wells PS, Ginsberg JS, Anderson DR, Kearon C, Gent M, Turpie AG, Bormanis J, Weitz J, Chamberlain M, Bowie D et al. Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann Intern Med 1998;129:997-1005.
-
(1998)
Ann Intern Med
, vol.129
, pp. 997-1005
-
-
Wells, P.S.1
Ginsberg, J.S.2
Anderson, D.R.3
Kearon, C.4
Gent, M.5
Turpie, A.G.6
Bormanis, J.7
Weitz, J.8
Chamberlain, M.9
Bowie, D.10
-
97
-
-
84866236261
-
Detection of a procoagulable state during controlled ovarian hyperstimulation for in vitro fertilization with global assays of haemostasis
-
Westerlund E, Henriksson P, WallenH, Hovatta O, Wallberg KR, Antovic A. Detection of a procoagulable state during controlled ovarian hyperstimulation for in vitro fertilization with global assays of haemostasis. Thromb Res 2012;130:649-653.
-
(2012)
Thromb Res
, vol.130
, pp. 649-653
-
-
Westerlund, E.1
Henriksson, P.2
Wallen, H.3
Hovatta, O.4
Wallberg, K.R.5
Antovic, A.6
-
98
-
-
84882632327
-
WHO (World Health Organization).
-
Geneva:World Health Organization, 4th edn
-
WHO (World Health Organization). Medical eligibility criteria for contraceptive use, 4th edn. Geneva:World Health Organization, 2011.
-
(2011)
Medical eligibility criteria for contraceptive use
-
-
-
99
-
-
0031855374
-
A randomized controlled double-blind study of the effects on hemostasis of two progestogen-only pills containing 75mg desogestrel or 30mg levonorgestrel
-
Winkler UH, Howie H, Buhler K, Korver T, Geurts TBP, Coelingh Bennink HJT. A randomized controlled double-blind study of the effects on hemostasis of two progestogen-only pills containing 75mg desogestrel or 30mg levonorgestrel. Contraception 1998;57:385-392.
-
(1998)
Contraception
, vol.57
, pp. 385-392
-
-
Winkler, U.H.1
Howie, H.2
Buhler, K.3
Korver, T.4
Geurts, T.B.P.5
Coelingh Bennink, H.J.T.6
|